U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Stage IV Intermediate Grade Adult Non-Hodgkin Lymphoma

MedGen UID:
83613
•Concept ID:
C0280171
•
Neoplastic Process
Synonym: Stage IV Intermediate Grade Adult Non-Hodgkin's Lymphoma

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVStage IV Intermediate Grade Adult Non-Hodgkin Lymphoma

Professional guidelines

PubMed

Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
Leccisotti L, Maccora D, Malafronte R, D'Alò F, Maiolo E, Annunziata S, Rufini V, Giordano A, Hohaus S
J Cancer Res Clin Oncol 2023 Jul;149(7):2783-2791. Epub 2022 Jul 2 doi: 10.1007/s00432-022-04138-3. PMID: 35779106Free PMC Article
Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol 2022 Dec;97(12):1638-1651. Epub 2022 Oct 18 doi: 10.1002/ajh.26737. PMID: 36255040
Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity.
Sonnen R, Schmidt WP, Kuse R, Schmitz N
Br J Haematol 2002 Dec;119(3):634-9. doi: 10.1046/j.1365-2141.2002.03896.x. PMID: 12437637

Recent clinical studies

Etiology

Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol 2022 Dec;97(12):1638-1651. Epub 2022 Oct 18 doi: 10.1002/ajh.26737. PMID: 36255040
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH
Lancet Haematol 2018 Dec;5(12):e609-e617. doi: 10.1016/S2352-3026(18)30177-7. PMID: 30501868Free PMC Article
Signs, Symptoms and Complications of Non-Hodgkin's Lymphoma According to Grade and Stage in South Iran.
Dehghani M, Haddadi S, Vojdani R
Asian Pac J Cancer Prev 2015;16(8):3551-7. doi: 10.7314/apjcp.2015.16.8.3551. PMID: 25921177
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Economopoulos T, Dimopoulos MA, Mellou S, Pavlidis N, Samantas E, Nicolaides C, Tsatalas C, Papadopoulos A, Papageogriou E, Papasavvas P, Fountzilas G
Eur J Haematol 2002 Mar;68(3):135-43. doi: 10.1034/j.1600-0609.2002.01620.x. PMID: 12068793
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Straus DJ
Recent Results Cancer Res 2002;159:143-8. doi: 10.1007/978-3-642-56352-2_17. PMID: 11785838

Diagnosis

Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
Leccisotti L, Maccora D, Malafronte R, D'Alò F, Maiolo E, Annunziata S, Rufini V, Giordano A, Hohaus S
J Cancer Res Clin Oncol 2023 Jul;149(7):2783-2791. Epub 2022 Jul 2 doi: 10.1007/s00432-022-04138-3. PMID: 35779106Free PMC Article
Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol 2022 Dec;97(12):1638-1651. Epub 2022 Oct 18 doi: 10.1002/ajh.26737. PMID: 36255040
Signs, Symptoms and Complications of Non-Hodgkin's Lymphoma According to Grade and Stage in South Iran.
Dehghani M, Haddadi S, Vojdani R
Asian Pac J Cancer Prev 2015;16(8):3551-7. doi: 10.7314/apjcp.2015.16.8.3551. PMID: 25921177
Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
Kolokotronis A, Konstantinou N, Christakis I, Papadimitriou P, Matiakis A, Zaraboukas T, Antoniades D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 Mar;99(3):303-10. doi: 10.1016/j.tripleo.2004.03.028. PMID: 15716836
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor.
Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC
Blood 1993 Oct 1;82(7):2169-74. PMID: 8400266

Therapy

Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol 2022 Dec;97(12):1638-1651. Epub 2022 Oct 18 doi: 10.1002/ajh.26737. PMID: 36255040
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH
Lancet Haematol 2018 Dec;5(12):e609-e617. doi: 10.1016/S2352-3026(18)30177-7. PMID: 30501868Free PMC Article
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Economopoulos T, Dimopoulos MA, Mellou S, Pavlidis N, Samantas E, Nicolaides C, Tsatalas C, Papadopoulos A, Papageogriou E, Papasavvas P, Fountzilas G
Eur J Haematol 2002 Mar;68(3):135-43. doi: 10.1034/j.1600-0609.2002.01620.x. PMID: 12068793
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Straus DJ
Recent Results Cancer Res 2002;159:143-8. doi: 10.1007/978-3-642-56352-2_17. PMID: 11785838
MACOP-B regimen in non-Hodgkin's lymphoma.
Joensuu H, Turpeenniemi-Hujanen T
Acta Oncol 1992;31(6):657-61. doi: 10.3109/02841869209083849. PMID: 1281651

Prognosis

Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol 2022 Dec;97(12):1638-1651. Epub 2022 Oct 18 doi: 10.1002/ajh.26737. PMID: 36255040
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH
Lancet Haematol 2018 Dec;5(12):e609-e617. doi: 10.1016/S2352-3026(18)30177-7. PMID: 30501868Free PMC Article
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Economopoulos T, Dimopoulos MA, Mellou S, Pavlidis N, Samantas E, Nicolaides C, Tsatalas C, Papadopoulos A, Papageogriou E, Papasavvas P, Fountzilas G
Eur J Haematol 2002 Mar;68(3):135-43. doi: 10.1034/j.1600-0609.2002.01620.x. PMID: 12068793
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Straus DJ
Recent Results Cancer Res 2002;159:143-8. doi: 10.1007/978-3-642-56352-2_17. PMID: 11785838
MACOP-B regimen in non-Hodgkin's lymphoma.
Joensuu H, Turpeenniemi-Hujanen T
Acta Oncol 1992;31(6):657-61. doi: 10.3109/02841869209083849. PMID: 1281651

Clinical prediction guides

Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
Leccisotti L, Maccora D, Malafronte R, D'Alò F, Maiolo E, Annunziata S, Rufini V, Giordano A, Hohaus S
J Cancer Res Clin Oncol 2023 Jul;149(7):2783-2791. Epub 2022 Jul 2 doi: 10.1007/s00432-022-04138-3. PMID: 35779106Free PMC Article
Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol 2022 Dec;97(12):1638-1651. Epub 2022 Oct 18 doi: 10.1002/ajh.26737. PMID: 36255040
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH
Lancet Haematol 2018 Dec;5(12):e609-e617. doi: 10.1016/S2352-3026(18)30177-7. PMID: 30501868Free PMC Article
Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
Kolokotronis A, Konstantinou N, Christakis I, Papadimitriou P, Matiakis A, Zaraboukas T, Antoniades D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 Mar;99(3):303-10. doi: 10.1016/j.tripleo.2004.03.028. PMID: 15716836
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Economopoulos T, Dimopoulos MA, Mellou S, Pavlidis N, Samantas E, Nicolaides C, Tsatalas C, Papadopoulos A, Papageogriou E, Papasavvas P, Fountzilas G
Eur J Haematol 2002 Mar;68(3):135-43. doi: 10.1034/j.1600-0609.2002.01620.x. PMID: 12068793

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...